• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Potential of mRNA vaccines to become versatile cancer vaccines
World J Clin Oncol. 2022 Aug 24;13(8):663-674. doi: 10.5306/wjco.v13.i8.663.ABSTRACTFor centuries, therapeutic cancer vaccines have been developed and tried clinically. Way back in the late 19th century, the Father of Immunotherapy, William Coley had discovered that bacterial toxins were effective for inoperable sarcomas. In the 1970s, the Bacillus Calmette-Guérin (BCG) vaccine was repurposed, e.g., for advanced melanomas. Then, therapeutic cancer vaccines based on tumor-associated antigens (found on the surfaces of cancer cells) were tried clinically but apparently have not made a really significant clinical impact. For ...
Source: Clinical Prostate Cancer - September 26, 2022 Category: Cancer & Oncology Authors: Shiu-Ying Tsao Source Type: research

Development of Cancer Immunotherapies
Cancer Treat Res. 2022;183:1-48. doi: 10.1007/978-3-030-96376-7_1.ABSTRACTCancer immunotherapy, or the utilization of components of the immune system to target and eliminate cancer, has become a highly active area of research in the past several decades and a common treatment strategy for several cancer types. The concept of harnessing the immune system for this purpose originated over 100 years ago when a physician by the name of William Coley successfully treated several of his cancer patients with a combination of live and attenuated bacteria, later known as "Coley's Toxins", after observing a subset of prior patients e...
Source: Cell Research - May 13, 2022 Category: Cytology Authors: Diana C DeLucia John K Lee Source Type: research